What is EQ (EQ) stock price today?

EQ (EQ) is currently trading at $2.57, up 3.21% today.

What is EQ P/E ratio?

EQ's P/E ratio is -5.28. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is EQ return on equity (ROE)?

EQ's return on equity (ROE) is -75.86%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is EQ's market cap?

EQ has a market capitalization of $91.29M.

NASDAQ · Biotechnology

EQ (EQ) Stock

$2.57 +3.21% NASDAQ: EQ Healthcare

Valuation

Metric	Value
Price	$2.57
Market Cap	$91.29M
P/E Ratio	-5.28
P/B Ratio	2.52
P/S Ratio	0.00
EPS (TTM)	$-0.39
52-Week High	$3.45
52-Week Low	$0.27
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-75.86%
ROA	-68.75%
ROCE	-82.76%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.01
Current Ratio	10.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$16.0M	$36.0M	$41.0M	$0
Operating Profit	$-38.0M	$-62.0M	$-15.0M	$-8.0M	$-24.0M
Net Profit	$-39.0M	$-62.0M	$-13.0M	$-8.0M	$-22.0M
EPS	$-1.35	$-3.19	$-0.38	$-0.23	$-0.39
Op Margin	—	-393.9%	-40.2%	-20.1%	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$85.0M	$78.0M	$51.0M	$26.0M	$32.0M
Total Liabilities	$19.0M	$46.0M	$28.0M	$7.0M	$3.0M
Cash	$50.0M	$59.0M	$23.0M	$18.0M	$30.0M
Borrowings	$12.0M	$10.0M	$1.0M	$0	$1.0M

Latest News

Piper Sandler Initiates Coverage on Equillium With Overweight Rating, $20 Price Target MT Newswires · Jul 13, 2026 Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504 Insider Monkey · Jun 10, 2026 Equillium Insider Sold Shares Worth $723,830, According to a Recent SEC Filing MT Newswires · Jun 5, 2026 Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jun 2, 2026 Equillium Insider Sold Shares Worth $267,209, According to a Recent SEC Filing MT Newswires · Jun 1, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-32.0M	$-9.0M	$-22.0M	$-19.0M	$-23.0M
Investing Cash Flow	$27.0M	$18.0M	$-5.0M	$14.0M	$4.0M
Financing Cash Flow	$1.0M	$0	$0	$0	$0
Net Cash Flow	$26.0M	$9.0M	$-36.0M	$-5.0M	$12.0M
Free Cash Flow	$-32.0M	$-9.0M	$-22.0M	$-19.0M	$-23.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-25.86%
Quick Ratio	18.62
Interest Coverage	—
Return 1Y	586.84%
Return 3Y	200.00%
Return 5Y	-53.39%

Ownership

Insiders Held16.05%

Institutions Held64.31%

Institutions Float Held76.60%

Institutional Holder	Shares	Report Date
Janus Henderson Group PLC	6,494,571	2026-03-31
Adage Capital Partners GP L.L.C.	5,329,416	2026-03-31
Decheng Capital LLC	4,447,308	2026-03-31
Adar1 Capital Management, LLC	3,726,659	2026-03-31
Woodline Partners LP	3,500,901	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
COEPCoeptis Therapeutics Holdings, Inc.	$10.99	-8.57%	-4.45	$38.62M	0.00%
CUE	$32.57	+1.40%	-4.05	$85.59M	0.00%
FBIO	$2.67	-3.61%	0.91	$88.69M	0.00%
IPSC	$2.02	-1.46%	-5.04	$174.87M	0.00%
MDCX	$0.28	-12.01%	-0.71	$6.17M	0.00%

About EQ

EQ is led by CEO Bruce D. Steel, employs 35 people, headquartered in US, publicly traded since 2018.

EQ stock trades at $2.57 with a market capitalization of $91.29M. The stock is valued at a price-to-earnings (P/E) ratio of -5.28, price-to-book of 2.52, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.27 and $3.45, and currently trades 25.5% below its 52-week high.

On profitability, EQ generates a return on equity (ROE) of -75.86%, return on capital employed of -82.76%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides